Somatostatin New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 51110-01-1 | Cat. No. | BCP04492 |
| Name | Somatostatin | ||
| Synonyms | Somatofalk; | ||
| SMILES | |||
| Chemical Name | |||
| Formula | C76H104N18O19S2 | M. Wt | 1637.88 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Somatostatin, also known as growth hormone-inhibiting hormone, is a naturally-occurring peptide hormone of 14 or 28 amino acid residues [T28] that regulates the endocrine system. It is secreted by the D cells of the islets to inhibit the release of insulin and glucagon, and is also generated in the hypothalamus, where it inhibits the release of growth hormone and thyroid-stimulating hormones from the anterior pituitary [T28]. Somatostatin is initially secreted as a 116 amino acid precursor, preprosomatostatin, which undergoes endoproteolytic cleavage to prosomastatin. Prosomastatin is further process into two active forms, somatostatin-14 (SST-14) and somatostatin-28 (SST-28), an extended SST-14 sequence to the N-terminus [A20384]. The actions of somatostatin are mediated via signalling pathways of G protein-coupled somatostatin receptors. Antineoplastic effects and potential uses of somatostatin on various tumours, including pituitary adenomas, GEP-NETs, paragangliomas, carcinoids, breast cancers, malignant lymphoma and small-cell lung cancers, have been extensively investigated [A20384]. Somatostatin has been used in the clinical setting for the diagnosis of acromegaly and gastrointestinal tract tumours. Its analogues have been developed to achieve more favourable kinetics for efficiency use in the management of acute conditions, such as esophageal varices. [DB00104] is a long-acting analogue of somatostatin that inhibits the release of a number of hormones, and is clinically used to relieve symptoms of uncommon gastroenteropancreatic endocrine tumours, as well as treat acromegaly [T28]. | ||
Recommend Products
More >
-
-
-
-
-
Palmitoyl Tripeptide-8
Cat. No.：BCP49067
No.：936544-53-5
Product Details -
Recombinant Kex2 protease
Cat. No.：BCP49060
No.：99676-46-7
Product Details -
-
-
Human lactoferrin peptide 1-11
Cat. No.：BCP49036
No.：183623-03-2
Product Details -
-
-
-
-
Hexapeptide-10
Cat. No.：BCP25059
No.：146439-94-3
Product Details -
Acetyl tetrapeptide-2
Cat. No.：BCP25056
No.：757942-88-4
Product Details -
Palmitoyl tetrapeptide-7
Cat. No.：BCP25054
No.：221227-05-0
Product Details -
-
Acetyl Tetrapeptide-9
Cat. No.：BCP25049
No.：928006-50-2
Product Details -
Z-VAL-ALA-OH
Cat. No.：BCP24510
No.：24787-89-1
Product Details -
Rotigaptide
Cat. No.：BCP24086
No.：355151-12-1
Product Details
Tags:Somatostatin supplier,Somatostatin purchase,Somatostatin manufacturer,Somatostatin distributor,Somatostatin cost,Somatostatin buy,Somatostatin for sale